Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Fortner

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
JAMA|August 14, 1972
Reduction in serum CO 2 during hyperalimentationC L Fortner
Journal of the American Pharmaceutical Association|May 1, 1976
Carcinoma of the breastW R Grove, C L Fortner
American Journal of Hospital Pharmacy|February 1, 1971
Reduction in serum CO2 content during hyperalimentation therapyC L Fortner, T Foley, J C Cradock
Clinical Pharmacy|July 1, 1982
Review of amsacrine, an investigational antineoplastic agentW R Grove, C L Fortner, P H Wiernik
Journal of the American Pharmaceutical Association|March 1, 1973
Hodgkin's diseaseW A Cornelis, D G Christian, C L Fortner
American Journal of Hospital Pharmacy|August 1, 1971
A unit dose system for handling parenteral investigational cancer chemotherapeutic agentsJ W Menzie, C L Fortner, J C Cradock
Drug Intelligence & Clinical Pharmacy|January 1, 1985
Combination antiemetic therapy in the control of chemotherapy-induced emesisC L Fortner, R S Finley, W R Grove
Pharmacotherapy|November 1, 1982
Piperacillin sodium: antibacterial spectrum, pharmacokinetics, clinical efficacy, and adverse reactionsC L Fortner, R S Finley, S C Schimpff
American Journal of Hospital Pharmacy|December 1, 1978
Audit of the de Haen Drugs-In-Use Drug Information SystemW R Grove, P P Lamy, C L Fortner
Journal of the American Pharmaceutical Association|September 1, 1972
The acute leukemiasD G Christian, W A Cornelis, C L Fortner
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
JAMA|August 14, 1972
Reduction in serum CO 2 during hyperalimentationC L Fortner
Journal of the American Pharmaceutical Association|May 1, 1976
Carcinoma of the breastW R Grove, C L Fortner
American Journal of Hospital Pharmacy|February 1, 1971
Reduction in serum CO2 content during hyperalimentation therapyC L Fortner, T Foley, J C Cradock
Clinical Pharmacy|July 1, 1982
Review of amsacrine, an investigational antineoplastic agentW R Grove, C L Fortner, P H Wiernik
Journal of the American Pharmaceutical Association|March 1, 1973
Hodgkin's diseaseW A Cornelis, D G Christian, C L Fortner
American Journal of Hospital Pharmacy|August 1, 1971
A unit dose system for handling parenteral investigational cancer chemotherapeutic agentsJ W Menzie, C L Fortner, J C Cradock
Drug Intelligence & Clinical Pharmacy|January 1, 1985
Combination antiemetic therapy in the control of chemotherapy-induced emesisC L Fortner, R S Finley, W R Grove
Pharmacotherapy|November 1, 1982
Piperacillin sodium: antibacterial spectrum, pharmacokinetics, clinical efficacy, and adverse reactionsC L Fortner, R S Finley, S C Schimpff
American Journal of Hospital Pharmacy|December 1, 1978
Audit of the de Haen Drugs-In-Use Drug Information SystemW R Grove, P P Lamy, C L Fortner
Journal of the American Pharmaceutical Association|September 1, 1972
The acute leukemiasD G Christian, W A Cornelis, C L Fortner
Pageof 4